Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer.

Authors

Jianqing Lin, George Washington University
Robert B. Den
Jacob Greenspan
Timothy N. Showalter
Jean H. Hoffman-Censits
Costas D. Lallas
Edouard J. Trabulsi
Leonard G. Gomella
Mark D. Hurwitz
Benjamin Leiby
Adam P. Dicker
W Kevin Kelly

Document Type

Journal Article

Publication Date

2-3-2020

Journal

International Journal of Radiation, Oncology, Biology, Physics

DOI

10.1016/j.ijrobp.2019.11.418

Comments

Epub ahead of print

APA Citation

Lin, J., Den, R. B., Greenspan, J., Showalter, T. N., Hoffman-Censits, J. H., Lallas, C. D., Trabulsi, E. J., Gomella, L. G., Hurwitz, M. D., Leiby, B., Dicker, A. P., & Kelly, W. (2020). Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer.. International Journal of Radiation, Oncology, Biology, Physics, (). http://dx.doi.org/10.1016/j.ijrobp.2019.11.418

Peer Reviewed

1